GL1X · GenesisL1 explorer

MolNFT v1 · #109357 · protein

Structure of M. tuberculosis nicotinate mono nucleotide adenylyltransferase

4X0E · Probable nicotinate-nucleotide adenylyltransferase: “Structure of M. tuberculosis nicotinate mono nucleotide adenylyltransferase”. X-ray diffraction, 1 ligand (SO4), 8 pockets (best druggability 0.70). MolNFT v1 #109357 on…

PDB
4X0E
Type
protein
Length
369 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Probable nicotinate-nucleotide adenylyltransferase
EC
2.7.7.18
UniProt
P9WJJ5
Ligands
SO4
Pockets
8 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable nicotinate-nucleotide adenylyltransferase (EC 2.7.7.18)protein19242% helix, 18% strandP9WJJ5
BProbable nicotinate-nucleotide adenylyltransferase (EC 2.7.7.18)protein17746% helix, 21% strandP9WJJ5

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains B
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13600.700.8342SO4
24380.670.7948empty
3520.460.8412empty
4500.450.8416empty
5590.440.8316empty

Interfaces

1 interface between chains.

  • A–B · 935 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 4X0E · Structure of M. tuberculosis nicotinate mono nucleotide adenylyltransferase · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WJJ5 · AlphaFold monomer V2.0 prediction for probable nicotinate-nucleotide adenylyltransferase… · a predicted model of the same protein · chain B against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.